Lanosterol

Lanosterol

SCHEMBL20225105

CC(C)=CCC[C@@H](C)C1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CCC(O)C(C)(C)C1CC3

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 1.00
▸ USP2 O75604 2/20 1.00
▸ ALDH1A1 P00352 2/20 1.00
▸ CYP3A4 P08684 2/20 1.00
▸ ALOX15 P16050 2/20 1.00
▸ CRYAB P02511 2/20 1.00
▸ LMNA P02545 1/20 1.00
▸ PTGES O14684 4/20 0.79
▸ FNTA P49354 1/20 0.74
▸ FNTB P49356 1/20 0.74
▸ CRYAA P02489 1/20 0.71
▸ ACHE P22303 1/20 0.62
▸ MEN1 O00255 1/20 0.61
▸ PLA2G1B P04054 1/20 0.61
▸ DNMT1 P26358 1/20 0.61
▸ BLM P54132 1/20 0.61
▸ KMT2A Q03164 1/20 0.61
▸ ATG4B Q9Y4P1 1/20 0.61
▸ HMGCR P04035 1/20 0.61
▸ PREP P48147 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lanosterol SCHEMBL18688634 1.00 MAPT (1.00) MAPTUSP2ALDH1A1CYP3A4ALOX15
Lanosterol SCHEMBL1242765 1.00 MAPT (1.00) MAPTUSP2ALDH1A1CYP3A4ALOX15
Lanosterol SCHEMBL17428540 1.00 MAPT (1.00) MAPTUSP2ALDH1A1CYP3A4ALOX15
Lanosterol SCHEMBL288881 1.00 MAPT (1.00) MAPTUSP2ALDH1A1CYP3A4ALOX15
Lanosterol SCHEMBL11914239 1.00 MAPT (1.00) MAPTUSP2ALDH1A1CYP3A4ALOX15
Euphol SCHEMBL541497 1.00 MAPT (1.00) MAPTUSP2ALDH1A1CYP3A4ALOX15
Lanosterol SCHEMBL1952146 1.00 MAPT (1.00) MAPTUSP2ALDH1A1CYP3A4ALOX15
Lanosterol SCHEMBL15977092 1.00 MAPT (1.00) MAPTUSP2ALDH1A1CYP3A4ALOX15
Lanosterol SCHEMBL21348006 1.00 MAPT (1.00) MAPTUSP2ALDH1A1CYP3A4ALOX15
Lanosterol SCHEMBL244737 1.00 MAPT (1.00) MAPTUSP2ALDH1A1CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10758579-B2 Systems and methods for extraction of natural products METAGREEN VENTURES (US) 2020-09-01 — — US disclosed
US-20180153948-A1 SYSTEMS AND METHODS FOR EXTRACTION OF NATURAL PRODUCTS METAGREEN VENTURES 2018-06-07 — — US disclosed
US-20180153948-A1 SYSTEMS AND METHODS FOR EXTRACTION OF NATURAL PRODUCTS METAGREEN VENTURES 2018-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180153948-A1 SYSTEMS AND METHODS FOR EXTRACTION OF NATURAL PRODUCTS LSS, HPSE, GUSB MAPT 4168/4885USP2 3316/4885ALDH1A1 4431/4885
US-10758579-B2 Systems and methods for extraction of natural products LSS, HPSE, GUSB MAPT 4168/4885USP2 3316/4885ALDH1A1 4431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback